Intranasal vaccines new ray of hope to halt COVID-19 transmission https://ift.tt/gdJK9Yu

For mass vaccinations, one should always look at a whole virion because that is the crux of developing antibodies for any variants which will come up so this Codagenix’s technology seems to be a very nice technology when it's a complete virion, Dr Ashish Sahai, Additional Director, Production (viral vaccines), SII informed while speaking to ETHealthworld on the development of COVI-VAC, an intranasal COVID-19 vaccine and the technology used to develop it.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/IZaOWC1